Roberto Nitsch

Years Active: 2020-2022
Publications (10 Years): 3

AstraZeneca R and D Mölndal

Università degli Studi di Napoli Federico II (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca R and D Mölndal

Sweden

Associate Director :: CPSS - Clinical Pharmacology and Safety Science

IMBA - Institute of Molecular Biotechnology

Austria

Postdoc

Education History

Università degli Studi di Napoli Federico II

Italy

PHD

Università degli Studi di Napoli Federico II

Italy

MSC

Publications

Felix M Dobbs, Patrick van Eijk, Mick D Fellows, Luisa Loiacono, Roberto Nitsch, Simon H Reed
Precision digital mapping of endogenous and induced genomic DNA breaks by INDUCE-seq. Nature communications 13 (1) (2022)
Mikko Hölttä, Roberto Nitsch, Neil Henderson
Bioanalytical challenges and strategies of CRISPR genome editors. Bioanalysis 13 (3) (2021)
Anders Lundin, Michelle J Porritt, Himjyot Jaiswal, Frank Seeliger, Camilla Johansson, Abdel Wahad Bidar, Lukas Badertscher, Sandra Wimberger, Emma J Davies, Elizabeth Hardaker, Carla P Martins, Emily James, Therese Admyre, Amir Taheri-Ghahfarokhi, Jenna Bradley, Anna Schantz, Babak Alaeimahabadi, Maryam Clausen, Xiufeng Xu, Lorenz M Mayr, Roberto Nitsch, Mohammad Bohlooly-Y, Simon T Barry, Marcello Maresca
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery. Nature communications 11 (1) (2020)

Roberto Nitsch.css-eqlu8i{font-size:small;padding-left:4px;}